Multiple myeloma associated with solid tumors
DOI:
https://doi.org/10.35954/SM1998.20.1.7Keywords:
Associated neoplasias, multiple myeloma, solid tumoursAbstract
The association of multiple myeloma (MM) with a solid tumor is an infrequent situation that generates diagnostic difficulties, reciprocal interferences in the treatment of both neoplasms and aggravates the prognosis. The evolution of one of these neoplasms can mask the clinical manifestations of the second. Three clinical cases of this association are presented, which occurred in our series of 31 multiple myelomas (10 %).
Translated with www.DeepL.com/Translator (free version)
Downloads
Metrics
References
(1) CZERNY V. Nachtarag zur darm resection. LIN Wochenschr 1880; 17: 683-684.
(2) WARRENS S, GATES O. Multiple primary malignant tumors. A survery of literature and statistical study. Am J Cancer 1932; 16:1358-1414.
(3) KAPSINOW R. Multiple primary cancer. J State Med 1962; 114: 194-199.
(4) CANO A, ARAMBURU J, DE LA CALLE A. Carcinomas primitivos múltiples. Med Clin (Barc) 1978; 70: 289-293.
(5) RIBERA JM, RUIZ DE AGUILAR A, PIELTAIN R. Neoplasias primitivas dobles. Med Clin (Barc) 1981; 76:421-426.
(6) HADJU SI, HADJU EO. Multiple primary malignant tumors. J Am Geriatric Soc 1968; 16: 16-26.
(7) CLEAR JV, KAZARIAN KK, MERSHEIMER WL. Multiple primary cancer. Am J Surg 1975; 129: 686-690.
(8) WEISS AM, HOREL F, POTET F. Les cancers multiples. Résultats de 2813 autopsies. Nouv Presse Med1980; 9: 355-357.
(9) WATANABE S. Multiple primary neoplsmas: role of autopsy, selected sites, with emphasis on Japan. Cancer Growth Prog 1989; 3: 35-39.
(10) COFFMAN B, CRUM E, FORMAN W. Two primary carcinomas of the lung: adenocarcinoma and a metachronous squamous carcinoma. Cancer 1983; 51: 124-126.
(11) TUNG-KWANG L, BARRINGER M, MYERS RT, STERCHI JM. Multiple primary carcinomas of the colon and associated extracolonic primary malignant tumors. Am J Surg 1982; 195: 501-507.
(12) HADJU SI, THOMAS AG. Renal cell carcinoma at autopsy. J Urol 1967; 97: 978-982.
(13) WEITZEL RA. Carcinoma coexistent with malignant disorders of plasma cells: an autopsy survey. Cancer 1958; 11: 546-549.
(14) KYLE RA. Multiple myeloma: review of 869 cases. Mayo Clin Proc 1975; 50: 29-40.
(15) BUCKMAN R, CUZICK J, GALTON DAG. Long- term survival in myelomatosis. Br J Haematol 1982; 52: 589-599.
(16) STEGMAN R, ALEXANIAN R. Solid tumors in multiple myeloma. Ann Intern Med 1979; 90: 780- 782.
(17) MUNÁRRIZ EB. Estudio de los factores pronósticos en el mieloma múltiple. Tesis Doctoral. Universidad de Valencia. Setiembre 1990.
(18) APARICIO J, RAMOS V, GOMEZ J, ALBEROLA C, GOMEZ L, MONTALAR J. Presentación monosintomática de dos neoplasias sincrónicas: mieloma múltiple y adenocarcinoma de próstata. Neoplasia 1993; 10 (1): 27-29.
(19) LI FP. Secondary cancers. En: De Vita VT Jr, Hellman S, Rosemberg SA, eds. Cancer . Principles and practice of Oncology (2da. ed.). Filadelfia, Lippincott, 1985; 2040-2049.
(20) COLEMAN CN, TUCKER MA. Secondary cancers. En: De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer. Principles and practice of Oncology (3a. ed.). Filadelfia, Lippincott, 1989; 2181-2190.
(21) COLEMAN CN, WILLIAMS CJ, Flint A. Hematologic neoplasia in patients treated for Hodgkin’s disease. N Engl J Med 1977; 297: 1249- 1252.
(22) BLAYNEY DW, LONGO DL, YOUNG RC. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin’s disease. N Engl J Med 1987; 316: 710- 714.
(23) TUCKER MA, COLEMAN CN, COX RS. Risk of second cancers after treatment for Hodgkin’s disease. N Engl J Med 1988; 318: 76-81.
(24) BERG JW. The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias and myeloma. J Nat Cancer Inst 1967; 38: 741-752.
(25) ROBINS SM, CHOPRA D. Multiple myeloma and multiple neoplasms. JAMA 1976; 236-1609.
(26) GONZÁLEZ F, TRUJILLO JM, ALEXANIAN R. Acute leukemia in multiple myeloma. Ann Intern Med 1977; 86:440-443.
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
